Nick Scali cuts his dividend again

Furniture retailer Nick Scali (ASX:NCK) hopes 2023-24 will be a year the market can forget, after cutting its dividend amid a 12-month slump in profits and sales.

The organization reported a 29% drop in profits as of mid-December 31, which narrowed in the second part of the year to a 20. 3% decline to $82. 1 million from $101. 1 million for 2022-2023.

Revenue fell 7. 8% to $468. 2 million, from $507. 7 million a year earlier.

The final dividend cut 2 cents per percentage to 33 cents, bringing the total for the year to 68 cents, from 75 cents per percentage. The interim dividend was reduced by five cents according to the percentage.

Nick Scali acquired British company Anglia Home Furnishing (trading as Fabb Furniture) on May 8, and his contribution is included from that date onwards.

The group’s profit for the year amounts to 468. 2 million dollars and 8. 3 million dollars for Fabb Furniture.

Revenue in Australia and New Zealand (ANZ) for the year ending June was $459. 9 million, which the company said was “in line with written order levels and typical delivery times. “

“Profits from the previous year benefited from higher deliveries as the June 2022 order bank narrowed and delivery times returned to pre-COVID levels. As a result, the group’s FY24 earnings declined by 7. 8% from last year and ANZ’s earnings by 9. 0%. decrease compared to last year.

The Group’s gross margin of 65. 6% for 2023-24 advanced by 2. 0% compared to FY23. Excluding Fabb Furniture, ANZ’s gross margin was 66. 0%, up 2. 5% from FY23, Nick Scali said on Friday.

Looking ahead to next year in Australia, New Zealand and the UK, Nick Scali was not optimistic.

While in Australia and New Zealand, “June 2024 benefited from five trading weekends, while July was deprived of one fewer weekend compared to calendar year 2023. “

“Written orders expansion for June and July combined is -1. 2% year-over-year. “

“We continue to expand the store network and expect to open two Nick Scali outlets and 3 to five Plush outlets in FY25. “

In the United Kingdom, “written orders have declined, affected by a combination of more challenging market conditions, longer delivery times due to disruptions in the origin chain, and the start of store renovations. “

“Commerce is expected to worsen further in the early part of FY25 as disruptions deepen due to store renovations and an update in the product mix. “

The latter comment was expected, given what Nick Scali’s control had to say about his acquisition in the United Kingdom and the market when the deal closed in May, but Australian investors will be looking for signs of improvement later this year.

Receive updates directly to your inbox.

Terms of use | Privacy Policy | Contact | Announce

 

 

Overall increases for Deep Leads’ resources: quality, tonnage and target area ABx Group has reported a 30% increase in its mineral resource estimate (MRE) at Deep Leads’ rare ion adsorption clay (IAC) earth deposit in northern Tasmania. The accumulation in MRE comes from 36 extension wells analyzed, representing a significant northward extension for the existing Deep Leads prospect.

Lake Resources (LKE. ASX) – LKE has signed two non-binding MoUs within 10 days. Ford Company (Ford) has signed a memorandum of understanding for about 25,000 t/year and last week, Hanwa, a Japanese raw materials trader, signed a memorandum of understanding for up to 25,000 t/year. Subject to execution, this is a feat as Ford and Hanwa are set to engage in long-term strategic partnerships with LKE. Trade negotiations are still ongoing but should, namely whether Ford and Hanwa will inject new capital into LKE, removing additional risks in financing the task and thus ensuring that LKE and Kachi are fully funded.

Two recent gravity studies have particularly exceeded expectations and revealed prospects for expansion of the existing MRE in Lake Throssell, as well as an opportunity for significant expansion in Lake Yeo. This reinforces the prospect of a multi-decade Tier 1 SOP production center around Lake Throssell.

Lately, TMG is completing paints in preparation for the PFS planned for early 2023, adding the start of drilling in Q3 2022, evaporation testing and permitting activities. The effects of these systems will affect the PFS and any long-term resource improvements.

The SOP reference values have increased to approximately $940/t due to recent geopolitical events. The October 2021 scoping study assumed an SOP value of $550/t and contained a sensitivity study showing that every 10% increased value effects in a $144 million NPV increase in the $364 million task NPV. The increase of approximately 70% compared to the scoping study implies a NPV allocation of approximately $1. 4 billion.

Despite the fall in oil and fuel prices, which fell by 5. 4% and 19. 7% respectively in August, Calima managed to show an improvement in its main indicators.

WT Financial Group Limited (WTL) is a fast-growing diversified monetary company, founded in 2010 and indexed to the Australia Securities Exchange (ASX) in 2015. Their recommendations and product offerings are primarily provided through an organization of independent money advisors acting as legal advisors. Representatives. WTL in connection with its broker organization activities Wealth Today Pty Ltd (Wealth Today) and Sentry Group Pty Ltd (Sentry Group). He has approximately 275 advisers at over two hundred money advisory firms across Australia. It also operates a direct-to-consumer operation under its Spring Financial Group brand.

In May 2021, Corporate Connect analyst Marc Sinatra published a full study report on ASX-listed biotech Immutep Ltd (ASX: IMM). He was so inspired by IMM that Corporate Connect found it imperative to publish a follow-up report that valued the company, as the market did not see the great prospects of eftilagimod alfa (efti).

This monitoring report was published today. Using comparables, after adding a dollar reduction to its EV estimate and dividing by the total number of percentages issued, Corporate Connect now puts the fair price of one percentage of Immutep at A$2. 20.

Leave a Comment

Your email address will not be published. Required fields are marked *